Detalhe da pesquisa
1.
Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 24(7): 798-810, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37290468
2.
Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter study.
BMC Med
; 21(1): 464, 2023 11 27.
Artigo
Inglês
| MEDLINE | ID: mdl-38012705
3.
Identifying optimal candidates for postoperative adjuvant therapy among regional persistent/recurrent nasopharyngeal carcinoma patients after neck dissection.
BMC Cancer
; 22(1): 1129, 2022 Nov 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36329397
4.
Prognostic significance of AKR1C4 and the advantage of combining EBV DNA to stratify patients at high risk of locoregional recurrence of nasopharyngeal carcinoma.
BMC Cancer
; 22(1): 880, 2022 Aug 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35953777
5.
First-Line Immunochemotherapy Versus Palliative Chemotherapy Plus Definitive Radiation Therapy for de novo Metastatic Nasopharyngeal Carcinoma: A Matched Cohort Study.
Cancer Control
; 29: 10732748221124868, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36047451
6.
Determining the suitability of definitive radiation therapy in patients with metastatic nasopharyngeal carcinoma based on PET/CT: a large cohort study.
Eur Radiol
; 32(11): 7722-7732, 2022 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-35505116
7.
Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CT.
Eur J Nucl Med Mol Imaging
; 48(8): 2586-2598, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33420610
8.
Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy.
BMC Cancer
; 21(1): 534, 2021 May 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33975558
9.
Percent change in apparent diffusion coefficient and plasma EBV DNA after induction chemotherapy identifies distinct prognostic response phenotypes in advanced nasopharyngeal carcinoma.
BMC Cancer
; 21(1): 1320, 2021 Dec 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34886807
10.
Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control study.
Eur Radiol
; 31(7): 5222-5233, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-33416977
11.
Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein-Barr virus DNA level.
BMC Cancer
; 20(1): 89, 2020 Feb 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32013967
12.
Maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography compared with Epstein-Barr virus DNA as prognostic indicators in de novo metastatic nasopharyngeal carcinoma patients.
BMC Cancer
; 19(1): 908, 2019 Sep 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31511059
13.
Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein-Barr virus DNA level and tumor response to palliative chemotherapy.
BMC Cancer
; 19(1): 92, 2019 Jan 21.
Artigo
Inglês
| MEDLINE | ID: mdl-30665378
14.
Neoadjuvant or Adjuvant Chemotherapy Plus Concurrent CRT Versus Concurrent CRT Alone in the Treatment of Nasopharyngeal Carcinoma: A Study Based on EBV DNA.
J Natl Compr Canc Netw
; 17(6): 703-710, 2019 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31200353
15.
Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial.
Lancet Oncol
; 19(4): 461-473, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29501366
16.
Symptomatic venous thromboembolism associated with peripherally inserted central catheters predicts a worse survival in nasopharyngeal carcinoma: results of a large cohort, propensity score-matched analysis.
BMC Cancer
; 18(1): 1297, 2018 Dec 29.
Artigo
Inglês
| MEDLINE | ID: mdl-30594171
17.
Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma.
BMC Cancer
; 18(1): 1279, 2018 Dec 20.
Artigo
Inglês
| MEDLINE | ID: mdl-30572856
18.
Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRT.
BMC Cancer
; 18(1): 114, 2018 01 31.
Artigo
Inglês
| MEDLINE | ID: mdl-29386004
19.
[The Policy and Practice of Preventive Care for the Elderly].
Hu Li Za Zhi
; 65(2): 13-19, 2018 Apr.
Artigo
Chinês
| MEDLINE | ID: mdl-29564852
20.
Advanced-Stage Nasopharyngeal Carcinoma: Restaging System after Neoadjuvant Chemotherapy on the Basis of MR Imaging Determines Survival.
Radiology
; 282(1): 171-181, 2017 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-27479804